Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 199
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Bednarska, Natalia G. van Eldere, Johan Gallardo, Rodrigo Ganesan, Ashok Ramakers, Meine Vogel, Isabel Baatsen, Pieter Staes, An Goethals, Marc Hammarström, Per Nilsson, K. Peter R. Gevaert, Kris Schymkowitz, Joost and Rousseau, Frederic 2016. Protein aggregation as an antibiotic design strategy. Molecular Microbiology, Vol. 99, Issue. 5, p. 849.

    Espargaró, Alba Busquets, Maria Antònia Estelrich, Joan and Sabate, Raimon 2016. Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion. Frontiers in Molecular Neuroscience, Vol. 9,

    Gillman, Alan L. Lee, Joon Ramachandran, Srinivasan Capone, Ricardo Gonzalez, Tania Wrasidlo, Wolf Masliah, Eliezer and Lal, Ratnesh 2016. Small molecule NPT-440-1 inhibits ionic flux through Aβ1-42 pores: Implications for Alzheimer's disease therapeutics. Nanomedicine: Nanotechnology, Biology and Medicine,

    Gupta, Amar Nath Neupane, Krishna Rezajooei, Negar Cortez, Leonardo M. Sim, Valerie L. and Woodside, Michael T. 2016. Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein. Nature Communications, Vol. 7, p. 12058.

    Herms, Jochen and Dorostkar, Mario M. 2016. Dendritic Spine Pathology in Neurodegenerative Diseases. Annual Review of Pathology: Mechanisms of Disease, Vol. 11, Issue. 1, p. 221.

    Ho, Chian Sing Khadka, Nawal K. She, Fengyu Cai, Jianfeng and Pan, Jianjun 2016. Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity. Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1858, Issue. 4, p. 661.

    Salahuddin, Parveen Fatima, Munazza Tamkeen Abdelhameed, Ali Saber Nusrat, Saima and Khan, Rizwan Hasan 2016. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches. European Journal of Medicinal Chemistry, Vol. 114, p. 41.

    Arya, Shruti Kumari, Arpana Dalal, Vijit Bhattacharya, Mily and Mukhopadhyay, Samrat 2015. Appearance of annular ring-like intermediates during amyloid fibril formation from human serum albumin. Phys. Chem. Chem. Phys., Vol. 17, Issue. 35, p. 22862.

    Chaudhary, Rajeev K Patel, Kinjal A Patel, Milan K Joshi, Radha H and Roy, Ipsita 2015. Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington’s Disease. Molecular Therapy, Vol. 23, Issue. 12, p. 1912.

    Côté, Sébastien Binette, Vincent Salnikov, Evgeniy S. Bechinger, Burkhard and Mousseau, Normand 2015. Probing the Huntingtin 1-17 Membrane Anchor on a Phospholipid Bilayer by Using All-Atom Simulations. Biophysical Journal, Vol. 108, Issue. 5, p. 1187.

    Dorostkar, Mario M. Zou, Chengyu Blazquez-Llorca, Lidia and Herms, Jochen 2015. Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities. Acta Neuropathologica, Vol. 130, Issue. 1, p. 1.

    Fantini, Jacques and Yahi, Nouara 2015. Brain Lipids in Synaptic Function and Neurological Disease.

    Gruden, Marina A. Davydova, Tatiana V. Narkevich, Victor B. Fomina, Valentina G. Wang, Chao Kudrin, Vladimir S. Morozova-Roche, Ludmilla A. and Sewell, Robert D.E. 2015. Noradrenergic and serotonergic neurochemistry arising from intranasal inoculation with α-synuclein aggregates which incite parkinsonian-like symptoms. Behavioural Brain Research, Vol. 279, p. 191.

    Henry, Sarah Vignaud, Hélène Bobo, Claude Decossas, Marion Lambert, Oliver Harte, Etienne Alves, Isabel D. Cullin, Christophe and Lecomte, Sophie 2015. Interaction of Aβ1–42Amyloids with Lipids Promotes “Off-Pathway” Oligomerization and Membrane Damage. Biomacromolecules, Vol. 16, Issue. 3, p. 944.

    Kristensen, Kasper Ehrlich, Nicky Henriksen, Jonas R. and Andresen, Thomas L. 2015. Single-Vesicle Detection and Analysis of Peptide-Induced Membrane Permeabilization. Langmuir, Vol. 31, Issue. 8, p. 2472.

    Papsdorf, Katharina Kaiser, Christoph J. O. Drazic, Adrian Grötzinger, Stefan W. Haeßner, Carmen Eisenreich, Wolfgang and Richter, Klaus 2015. Polyglutamine toxicity in yeast induces metabolic alterations and mitochondrial defects. BMC Genomics, Vol. 16, Issue. 1,

    Potapov, Alexey Yau, Wai-Ming Ghirlando, Rodolfo Thurber, Kent R. and Tycko, Robert 2015. Successive Stages of Amyloid-β Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization. Journal of the American Chemical Society, Vol. 137, Issue. 25, p. 8294.

    Sahu, Kamlesh Kumar Woodside, Michael T. and Tuszynski, Jack A. 2015. α-synuclein dimer structures found from computational simulations. Biochimie, Vol. 116, p. 133.

    Seneci, Pierfausto 2015. Molecular Targets in Protein Misfolding and Neurodegenerative Disease.

    Sin, Olga and Nollen, Ellen A. A. 2015. Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes. Cellular and Molecular Life Sciences, Vol. 72, Issue. 21, p. 4027.


Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

  • Hilal A. Lashuel (a1) and Peter T. Lansbury (a2)
  • DOI:
  • Published online: 01 September 2006

1. Introduction 2

2. What is the significance of the shared structural properties of disease-associated protein fibrils? 3

2.1 Mechanism of amyloid fibril formation in vitro 6

2.1.1 In vitro fibril formation involves transient population of ordered aggregates of intermediate stability, or protofibrils 6

3. Toxic properties of protofibrils 7

3.1 Protofibrils, rather than fibrils, are likely to be pathogenic 7

3.2 The toxic protofibril may be a mixture of related species 8

3.3 Morphological similarities of protofibrils suggest a common mechanism of toxicity 9

3.4 Are the amyloid diseases a subset of a much larger class of previously unrecognized protofibril diseases? 9

3.5 Fibrils, in the form of aggresomes, may function to sequester toxic protofibrils 9

4. Amyloid pores, a common structural link among protein aggregation neurodegenerative diseases 10

4.1 Mechanistic studies of amyloid fibril formation reveal common features, including pore-like protofibrils 10

4.1.1 Amyloid-β (Aβ) (Alzheimer's disease) 10

4.1.2 α-Synuclein (PD and diffuse Lewy body disease) 12

4.1.3 ABri (familial British dementia) 13

4.1.4 Superoxide dismutase-1 (amyotrophic lateral sclerosis) 13

4.1.5 Prion protein (Creutzfeldt–Jakob disease, bovine spongiform encephalopathy, etc.) 14

4.1.6 Huntingtin (Huntington's disease) 14

4.2 Amyloidogenic proteins that are not linked to disease also from pore-like protofibrils 15

4.3 Amyloid proteins form non-fibrillar aggregates that have properties of protein channels or pores 15

4.3.1 Aβ ‘channels’ 15

4.3.2 α-Synuclein ‘pores’ 16

4.3.3 PrP ‘channels’ 16

4.3.4 Polyglutamine ‘channels’ 17

4.4 Nature uses β-strand-mediated protein oligomerization to construct pore-forming toxins 17

5. Mechanisms of protofibril induced toxicity in protein aggregation diseases 19

5.1 The amyloid pore can explain the age-association and cell-type selectivity of the neurodegenerative diseases 19

5.2 Protofibrils may promote their own accumulation by inhibiting the proteasome 20

6. Testing the amyloid pore hypothesis by attempting to disprove it 21

7. Acknowledgments 22

8. References 22

Protein fibrillization is implicated in the pathogenesis of most, if not all, age-associated neurodegenerative diseases, but the mechanism(s) by which it triggers neuronal death is unknown. Reductionist in vitro studies suggest that the amyloid protofibril may be the toxic species and that it may amplify itself by inhibiting proteasome-dependent protein degradation. Although its pathogenic target has not been identified, the properties of the protofibril suggest that neurons could be killed by unregulated membrane permeabilization, possibly by a type of protofibril referred to here as the ‘amyloid pore’. The purpose of this review is to summarize the existing supportive circumstantial evidence and to stimulate further studies designed to test the validity of this hypothesis.

Corresponding author
Email: or
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Quarterly Reviews of Biophysics
  • ISSN: 0033-5835
  • EISSN: 1469-8994
  • URL: /core/journals/quarterly-reviews-of-biophysics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *